HMP Global

Oncology Learning Network

Health EN ↓ 191 episodes

Podcast by HMP Global

Be sure to visit the podcast's website and support the creator: soundcloud.com

Author

HMP Global

Category

Health

Podcast website

soundcloud.com

Latest episode

Nov 4, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Andreas Hochhaus, MD, Talks About the ASCEMBL Trial, Eliminating LSCs in CML 03.12.2020

In this podcast, Andreas Hochhaus, MD, University Medical Center Jena, Germany, discusses the significance of the ASCEMBL trial presented at the virtual 2020 ASH Annual Meeting and Exposition, and proposes the question of how to eliminate persisting leukemic stem cells (LSCs) in chronic myeloid leukemia (CML).

Andreas Hochhaus, MD, on Asciminib vs Bosutinib for Pretreated CML-CP 03.12.2020

In this podcast, Andreas Hochhaus, MD, University Medical Center Jena, Germany, discusses the use of asciminib versus bosutinib for the treatment of patients with chronic myeloid leukemia in chronic phase (CML-CP) previously given ≥2 tyrosine kinase inhibitors (TKIs). These data were presented at the virtual 2020 ASH Annual Meeting and Exposition.

Noopur Raje, MD, Talks Anti-BCMA CAR-T Therapy for Relapsed/Refractory MM 28.10.2020

In this video, Dr Raje discusses the clinical significance of anti-BCMA CAR-T therapy with bb2121 in patients with relapsed or refractory MM.

Dr Leonard Shares Highlights to Expect at the 2020 Leukemia, Lymphoma & Myeloma Congress 19.10.2020

Dr Leonard Shares Highlights to Expect at the 2020 Leukemia, Lymphoma & Myeloma Congress by HMP Global

Episode 4: Evolving Therapies in Ewing Sarcoma 15.10.2020

Episode 4: Evolving Therapies in Ewing Sarcoma by HMP Global

Abhishek Maiti, MD, Talks 10-Day Decitabine Plus Venetoclax for Intensive Chemo–Ineligible AML 15.10.2020

Abhishek Maiti, MD, Talks 10-Day Decitabine Plus Venetoclax for Intensive Chemo–Ineligible AML by HMP Global

Dr Nagourney on CRC Cells Treated with FOLFOX or CAPOX 02.10.2020

Dr Nagourney on CRC Cells Treated with FOLFOX or CAPOX by HMP Global

Dr Jazieh Highlights the Prevalence of ALK+ NSCLC in the Middle East and North Africa 28.09.2020

Abdul Rahman Jazieh, MD, MPH, National Guard Health Affairs, Riyadh, Saudi Arabia, discusses a study on the presence of ALK+ NSCLC in the Middle East and North Africa, presented at the ESMO 2020 Virtual Congress.

Episode 3: Standard of Care Treatment for Ewing Sarcoma 24.09.2020

Brian Van Tine, MD, PhD, and Robert “Bob” Maki, MD, PhD, discuss recent data comparing the American Standard versus European Standard for treatment of Ewing sarcoma.

Sarcoma Soundbites with Brian and Bob: Ewing Sarcoma, Part 1 24.09.2020

Sarcoma Soundbites with Brian and Bob: Ewing Sarcoma, Part 1 by HMP Global

Dr Percival on New AML Treatments 22.09.2020

Dr Percival on New AML Treatments by HMP Global

Combo of RAF/MEK Inhibitor and Defactinib Shows Promise in Patients With KRAS+ Ovarian Cancer 22.09.2020

In an interview with Oncology Learning Network, Udai Banerji, MD, NIHR Professor of Molecular Cancer Pharmacology, The Institute of Cancer Research, London, United Kingdom, discussed the findings and clinical significance of a phase 1 trial evaluating the use of VS-6766, a RAF/MEK inhibitor, plus defactinib, a FAK inhibitor, in patients with KRAS-mutant ovarian cancer.

Veena Shankaran, MD, MS, Discusses Financial Hardships in Patients With Metastatic CRC 02.09.2020

Veena Shankaran, MD, MS, Discusses Financial Hardships in Patients With Metastatic CRC by HMP Global

What to Expect at the Non-Malignant Hematology Workshop at Lymphoma, Leukemia & Myeloma Congress 24.08.2020

What to Expect at the Non-Malignant Hematology Workshop at Lymphoma, Leukemia & Myeloma Congress by HMP Global

Dr Jabbour on Management of Ph+ and Ph-like ALL 21.08.2020

Dr Jabbour on Management of Ph+ and Ph-like ALL by HMP Global

Christopher Crane, MD, Discusses Benefits of Long-Course Vs Short-Course RT for Rectal Cancer 14.08.2020

Christopher Crane, MD, Discusses Benefits of Long-Course Vs Short-Course RT for Rectal Cancer by HMP Global

CAR T-Cell Therapy Promising for Relapsed, Refractory Large B-Cell NHL 06.08.2020

CAR T-Cell Therapy Promising for Relapsed, Refractory Large B-Cell NHL by HMP Global

Long-term Follow Up of First-line NALIRIFOX in Pancreatic Cancer 02.07.2020

Long-term Follow Up of First-line NALIRIFOX in Pancreatic Cancer by HMP Global

Interim Analysis Suggests Correlation Between Ponatinib Dosing and Efficacy in CML 11.06.2020

Interim Analysis Suggests Correlation Between Ponatinib Dosing and Efficacy in CML by HMP Global

No DFS Benefit With Adjuvant Atezolizumab for High-Risk Urothelial Carcinoma 09.06.2020

Petros Grivas, MD, PhD, talks about the importance of the IMvigor010 clinical trial, which assessed the use of adjuvant atezolizumab in patients with muscle-invasive urothelial cancer.

Faster Corticosteroid Tapering Safe in Relapsed/Refractory MM 05.06.2020

Faster Corticosteroid Tapering Safe in Relapsed/Refractory MM by HMP Global

BCMA-Directed CAR-T Therapy Shows Promise in Heavily Pretreated MM 02.06.2020

BCMA-Directed CAR-T Therapy Shows Promise in Heavily Pretreated MM by HMP Global

Triplet Combo Well-Tolerated, Effective for IDH1-Mutated AML 31.05.2020

Triplet Combo Well-Tolerated, Effective for IDH1-Mutated AML by HMP Global

Shirish Gadgeel, MD, Discusses Follow-Up Results of Pembrolizumab with Chemotherapy for NSCLC 29.04.2020

Shirish Gadgeel, MD, Discusses Follow-Up Results of Pembrolizumab with Chemotherapy for NSCLC by HMP Global

COA Annual Conference Goes Virtual for 2020 24.04.2020

Bo Gamble, Director of Strategic Practice Initiatives, Community Oncology Alliance (COA) discusses how, in the face of the COVID-19 pandemic, COA is standing strong and readjusting to cater to the needs of community oncologists nationwide.

Listen to the Oncology Learning Network podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.